BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12447007)

  • 1. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
    Kumarasamy N; Mahajan AP; Flanigan TP; Hemalatha R; Mayer KH; Carpenter CC; Thyagarajan SP; Solomon S
    J Acquir Immune Defic Syndr; 2002 Dec; 31(4):378-83. PubMed ID: 12447007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total lymphocyte count as a tool for timing opportunistic infection prophylaxis in resource-limited settings: a study from India.
    Srirangaraj S; Venkatesha D
    J Infect Dev Ctries; 2010 Oct; 4(10):645-9. PubMed ID: 21045357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.
    Obirikorang C; Quaye L; Acheampong I
    BMC Infect Dis; 2012 Jun; 12():128. PubMed ID: 22676809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
    van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total lymphocyte count as a surrogate marker for CD4+ t cell count in initiating antiretroviral therapy at Kenyatta National Hospital, Nairobi.
    Gitura B; Joshi MD; Lule GN; Anzala O
    East Afr Med J; 2007 Oct; 84(10):466-72. PubMed ID: 18232267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
    Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii prophylaxis discontinuation based upon total lymphocyte count in HIV-infected adults treated with antiretroviral therapy.
    Cheung C; Shuter J
    Int J STD AIDS; 2010 Jun; 21(6):406-9. PubMed ID: 20606220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
    Spacek LA; Griswold M; Quinn TC; Moore RD
    AIDS; 2003 Jun; 17(9):1311-7. PubMed ID: 12799552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
    Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
    Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating total lymphocyte counts as a substitute for CD4 counts in the follow up of AIDS patients.
    Angelo AL; Angelo CD; Torres AJ; Ramos AM; Lima M; Netto EM; Brites C
    Braz J Infect Dis; 2007 Oct; 11(5):466-70. PubMed ID: 17962871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis.
    Martin DJ; Sim JG; Sole GJ; Rymer L; Shalekoff S; van Niekerk AB; Becker P; Weilbach CN; Iwanik J; Keddy K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):386-91. PubMed ID: 7882104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia.
    Wondimeneh Y; Ferede G; Yismaw G; Muluye D
    AIDS Res Ther; 2012 Jul; 9(1):21. PubMed ID: 22793790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation analysis on total lymphocyte count and CD4 count in HIV-infected patients: a retrospective evaluation.
    Wang Y; Liang S; Yu E; Guo J; Li Z; Wang Z; Du Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):712. PubMed ID: 22038367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
    Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
    J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 23442562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
    Wilhan ; Budiono E
    Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya.
    Githinji N; Maleche-Obimbo E; Nderitu M; Wamalwa DC; Mbori-Ngacha D
    BMC Infect Dis; 2011 Sep; 11():259. PubMed ID: 21961890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 counts in laboratory monitoring of HIV disease--experience from western India.
    Ingole N; Nataraj G; Mehta P; Paranjpe S; Sarkate P
    J Int Assoc Provid AIDS Care; 2014; 13(4):324-7. PubMed ID: 25513028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
    Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.